Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ABL1 | P00519 | 1/20 | 0.32 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601028 | 0.85 | CYP17A1 (0.38) | NPC1RAB9ATSHRMEN1KMT2A | |
| SCHEMBL25514964 | 0.84 | ALDH1A1 (0.32) | TSHRABL1RIN1MEN1KMT2A | |
| SCHEMBL19601020 | 0.80 | TSHR (0.47) | NPC1RAB9ATSHRABL1RIN1 | |
| SCHEMBL26011499 | 0.78 | CYP17A1 (0.35) | NPC1RAB9ATSHRMEN1KMT2A | |
| SCHEMBL19601024 | 0.77 | CYP17A1 (0.45) | NPC1RAB9ATSHRMEN1KMT2A | |
| SCHEMBL26061891 | 0.74 | ALDH1A1 (0.46) | NPC1RAB9ATSHRABL1RIN1 | |
| SCHEMBL26011494 | 0.74 | NPSR1 (0.40) | NPC1RAB9ATSHRABL1RIN1 | |
| SCHEMBL26063617 | 0.74 | MEN1 (0.30) | MEN1KMT2AALDH1A1 | |
| SCHEMBL19601027 | 0.74 | ALDH1A1 (0.34) | TSHRMEN1KMT2ANPSR1ALDH1A1 | |
| SCHEMBL25494127 | 0.73 | ALDH1A1 (0.30) | TSHRABL1RIN1NPSR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230161243-A1 | SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230161243-A1 | SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, ASIC1, REN | NPC1 3257/4885RAB9A 794/4885TSHR 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.